Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-23-033783

President and CEO acquired 2,766 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-31 Grant or award : show line 1 in the form +2,766 $3.46 $9,560 53,414 D
Loading xslF345X04/doc4.xml…